|
SIN3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08220005074133E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83186799063151E-13 |
| Normal-vs-Stage2 |
1.73219999999308E-05 |
| Normal-vs-Stage3 |
9.47131262307721E-13 |
| Normal-vs-Stage4 |
4.30849800281408E-11 |
| Stage1-vs-Stage2 |
3.741400E-01 |
| Stage1-vs-Stage3 |
1.945180E-01 |
| Stage1-vs-Stage4 |
7.035600E-02 |
| Stage2-vs-Stage3 |
9.719600E-02 |
| Stage2-vs-Stage4 |
5.973700E-02 |
| Stage3-vs-Stage4 |
6.188600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.74710040773607E-10 |
| Normal-vs-AfricanAmerican |
6.441400E-04 |
| Normal-vs-Asian |
8.92679996589152E-09 |
| Caucasian-vs-AfricanAmerican |
2.355600E-01 |
| Caucasian-vs-Asian |
8.995600E-01 |
| AfricanAmerican-vs-Asian |
2.430000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64769975441459E-10 |
| Normal-vs-Female |
2.39209985153366E-10 |
| Male-vs-Female |
5.643800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.44060327503348E-12 |
| Normal-vs-Age(41-60Yrs) |
7.01161351202018E-12 |
| Normal-vs-Age(61-80Yrs) |
3.82100018292419E-10 |
| Normal-vs-Age(81-100Yrs) |
1.921820E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.411000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.760200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.192800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.062600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.581200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.798600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.920090E-03 |
| Classical-VS-Follicular |
1.784210E-01 |
| Classical-VS-Other |
3.303400E-01 |
| Classical-VS-Normal |
1.71370000412452E-08 |
| Tall-VS-Follicular |
9.076400E-02 |
| Tall-VS-Other |
7.224800E-01 |
| Tall-VS-Normal |
3.80839804137167E-11 |
| Follicular-VS-Other |
6.541400E-01 |
| Follicular-VS-Normal |
7.70539965166961E-10 |
| Other-VS-Normal |
2.485000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.2948309919002E-13 |
| Normal-vs-N1 |
9.89375248394708E-12 |
| N0-vs-N1 |
5.285600E-02 |
|
|
